Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03898908
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-18
First Post:
2019-03-27
Brief Title:
Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Grupo Español Multidisciplinar de Melanoma
Organization Data
Organization:
Grupo Español Multidisciplinar de Melanoma
Class:
OTHER
Study ID:
GEM-1802
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grupo Español Multidisciplinar de Melanoma
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| MFAR | OTHER |
| Pierre Fabre Medicament | INDUSTRY |